17-160
Showing 51 - 75 of 7,879
Early Alzheimer´s Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Recruiting
- Early Alzheimer´s Disease
- Semaglutide
- Placebo (semaglutide)
-
Phoenix, Arizona
- +351 more
Mar 29, 2022
Heart Failure Trial in Tanta (Sacubitril / Valsartan Oral Tablet, Valsartan 160mg)
Recruiting
- Heart Failure
- Sacubitril / Valsartan Oral Tablet
- Valsartan 160mg
-
Tanta, Elgarbia, EgyptTanta University Hospital
May 31, 2023
High Risk of Stroke Trial in Hangzhou (Usual Diet advice, ORIENT diet intervention)
Not yet recruiting
- High Risk of Stroke
- Usual Diet advice
- ORIENT diet intervention
-
Hangzhou, Zhejiang, ChinaSecond Affilated Hospital of Zhejiang University, School of Medi
Oct 19, 2023
Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic
Not yet recruiting
- Metastatic Lung Cancer
- Metastatic Gastrointestinal Cancer
- FoundationOne® Liquid CDx Assay
- Standard of Care Diagnostic Pathway
- (no location specified)
May 11, 2023
Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)
Recruiting
- Uveitis, Posterior
- +3 more
- Ixekizumab Prefilled Syringe
-
Waltham, MassachusettsMassachusetts Eye Research and Surgery Institution
Oct 11, 2023
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Double-dose Furmonertinib in Treatment of Slow
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- (no location specified)
Oct 31, 2023
Breast Diseases, Mastodynia, Anxiety Trial in Durham (Ultrasound, Discussion)
Completed
- Breast Diseases
- +2 more
- Ultrasound
- Discussion
-
Durham, North CarolinaDuke University Medical Center
Dec 28, 2022
NSCLC Trial in Gyeonggi-do, Incheon, Seoul (Lazertinib, Pemetrexed, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- Lazertinib
- +2 more
-
Gyeonggi-do, Korea, Republic of
- +5 more
Jul 25, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)
Not yet recruiting
- Psoriasis
- 608 Q2W
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Huanshan Hospital Fudan University
Sep 8, 2022
Textbook Outcome in Colon Carcinoma
Completed
- Outcome Assessment
- Cancer of Colon
- Colon oncological resection
-
Alicante, SpainHospital General Universitario Dr. Balmis
Jan 5, 2023
COPD Trial in Rahim yar khan (Anterior Chest Compression technique, Abdominal Thrust Technique)
Not yet recruiting
- COPD
- Anterior Chest Compression technique
- Abdominal Thrust Technique
-
Rahim yar khan, Punjab, PakistanSheikh Zayed Hospital, Rahim Yar Khan.
Jul 7, 2023
Obesity, Childhood Trial (Baby-Feed, Limited access to the Baby-Feed web application)
Not yet recruiting
- Obesity, Childhood
- Baby-Feed
- Limited access to the Baby-Feed web application
- (no location specified)
Aug 11, 2023
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Education, Patient Trial in Izmir (Video-assisted training)
Active, not recruiting
- Education, Patient
- Video-assisted training
-
İzmir, Menemen, Turkeyizmir Bakircay University
Jun 21, 2023
Exercise Trial in Greenville (Types of Exercise)
Active, not recruiting
- Exercise
- Types of Exercise
-
Greenville, North CarolinaEast Carolina University
Jan 19, 2023
Augmented Reality Usage in Gynecological Laparoscopy on Patients
Active, not recruiting
- Myoma;Uterus
- Adenomyoma of Uterus
- Gynecological laparoscopic surgery without augmented reality
- Gynecological laparoscopic surgery with augmented reality
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2023
SGA, Turner Syndrome, Noonan Syndrome, ISS Trial (Somapacitan, Norditropin®)
Recruiting
- SGA, Turner Syndrome, Noonan Syndrome, ISS
-
Birmingham, Alabama
- +163 more
Feb 2, 2023
Opioid Use Disorder, Chronic Pain Trial (Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP),
Not yet recruiting
- Opioid Use Disorder
- Chronic Pain
- Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP)
- Enhance Usual Care (EUC)
- (no location specified)
Oct 5, 2022
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Chronic Pain, Opioid-use Disorder, Opioids; Harmful Use Trial in San Francisco, Albuquerque, Tacoma (ACT+MBRP, Education
Recruiting
- Chronic Pain
- +2 more
- ACT+MBRP
- Education control
-
San Francisco, California
- +3 more
Apr 18, 2022
Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Turoctocog alfa pegol)
Completed
- Congenital Bleeding Disorder
- Haemophilia A
- Turoctocog alfa pegol
-
Phoenix, Arizona
- +66 more
Dec 20, 2022